Hangzhou Alltest Biotech Co., Ltd. (SHA:688606)
China
· Delayed Price · Currency is CNY 64.15
+0.60 (0.94%)
Jun 20, 2025, 3:00 PM CST
Hangzhou Alltest Biotech Market Cap
Hangzhou Alltest Biotech has a market cap or net worth of 5.00 billion as of June 20, 2025. Its market cap has increased by 14.26% in one year.
Market Cap
5.00B
Enterprise Value
2.45B
Revenue
875.14M
Ranking
n/a
PE Ratio
15.90
Stock Price
64.15
Market Cap Chart
Since March 25, 2021, Hangzhou Alltest Biotech's market cap has decreased from 9.38B to 5.00B, a decrease of -46.72%. That is a compound annual growth rate of -13.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 20, 2025 | 5.00B | 1.75% |
| Dec 31, 2024 | 4.91B | -8.43% |
| Dec 29, 2023 | 5.36B | -2.86% |
| Dec 30, 2022 | 5.52B | -16.76% |
| Dec 31, 2021 | 6.63B | -29.28% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Medicine | 342.27B |
| Shenzhen Mindray Bio-Medical Electronics | 273.26B |
| WuXi AppTec | 186.05B |
| Zhangzhou Pientzehuang Pharmaceutical., | 120.72B |
| Sichuan Biokin Pharmaceutical | 118.38B |
| Aier Eye Hospital Group | 110.80B |
| Shanghai United Imaging Healthcare | 104.24B |
| Yunnan Baiyao Group Co.,Ltd | 98.19B |